The Utility of Salivary 11-Dehydrodexamethasone as a Marker of Dexamethasone Absorption

Clicks: 1
ID: 316949
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #336 of 362 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 362 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background The 1 mg overnight dexamethasone suppression test (ONDST) is recommended for the investigation of hypercortisolism and adrenal incidentalomas. Measurement of cortisol and dexamethasone (DXM) has been shown to improve diagnostic sensitivity of the ONDST. Recent work has shown that salivary cortisone collection can be undertaken at home replacing serum sampling, but previous studies have found poor performance of salivary DXM after the ONSDT. Herein we introduce the concept of measuring 11-dehydrodexamethasone (11-DHD): a DXM metabolite produced in the salivary duct by metabolism of 11β-hydroxysteroid dehydrogenase type 2, as a surrogate marker for DXM absorption. Methods Paired 0900h serum and saliva samples (n=90) were collected post-ONDST. Independent liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays were used to measure serum cortisol and DXM. A novel LC-MS/MS assay was developed to measure salivary cortisol, cortisone, DXM and 11-DHD. Results were compared and correlations were assessed using Pearson’s correlation coefficient. Results Serum and salivary DXM results exhibited a poor correlation (R-squared = 0.135). Salivary DXM and 11-DHD also correlated poorly (R-squared = 0.163). Serum DXM and salivary 11-DHD yielded a positive correlation with an R-squared of 0.75. Conclusion The positive relationship between serum DXM and salivary 11-DHD is novel. At higher concentrations of DXM, the correlation becomes somewhat curvilinear and more variable. A similar relationship is seen between salivary cortisol and cortisone. The development of a salivary 11-DHD LC-MS/MS assay has the potential to improve the current patient pathway. Patients could administer the drug and collect a 0900h-saliva sample at their convenience, prior to posting for analysis.
Reference Key
openalex_W7164385586 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors David Marshall, Basil Issa, Brian Keevil
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag236
URL
https://doi.org/10.1210/clinem/dgag236
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.